Stealth BioTherapeutics
Anthony Abbruscato is the Vice President of Clinical Development at Stealth BioTherapeutics. Anthony brings close to 10 years of experience between clinical practice, academia, and industry. In industry, he has held positions in translational medicine, clinical pharmacology, early clinical development, and late-stage clinical development across both large pharmaceutical and biotechnology companies. He received a Bachelor of Science and Doctor of Pharmacy degrees from Northeastern University, completed his residency training at NYU Langone Hospital, Long Island, and completed a post-doctoral industry Fellowship at the Novartis Institutes for Biomedical Research in translational oncology. Anthony holds a board certification as a Pharmacotherapy Specialist and has held a faculty appointment at Massachusetts College of Pharmacy and Health Sciences University.
This person is not in any offices
Stealth BioTherapeutics
1 followers
Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging.